| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/02/2011 | US20110130435 Time-released medication for applying to crustacean ovarian development |
| 06/02/2011 | US20110130434 Modified release ramipril compositions and uses thereof |
| 06/02/2011 | US20110130433 Hepatitis C Virus Inhibitors |
| 06/02/2011 | US20110130432 Heterocyclic Carboxamides For Use As Thrombin Inhibitors |
| 06/02/2011 | US20110130431 Compounds Which Modulate The CB2 Receptor |
| 06/02/2011 | US20110130429 Pyridines for treating injured mammalian nerve tissue |
| 06/02/2011 | US20110130428 Sublingual Compositions Comprising (2S) - (4E) -N-Methyl-5- (3- (5-Isopropoxypyridin) YL)-4-Penten-2-Amine |
| 06/02/2011 | US20110130426 Novel Sulphonamide Derivatives as Glucocorticoid Receptor Modulators for the Treatment of Inflammatory Diseases |
| 06/02/2011 | US20110130425 Use of H3 Histaminergic Agonists for the Treatment of Addiction to Drugs of Abuse |
| 06/02/2011 | US20110130424 Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties |
| 06/02/2011 | US20110130423 Compounds Which Have Activity At M1 Receptor And Their Uses In Medicine |
| 06/02/2011 | US20110130422 Biphenyl compounds useful as muscarinic receptor antagonists |
| 06/02/2011 | US20110130421 Methods and Compositions for the Treatment of Chronic Renal Hypertension |
| 06/02/2011 | US20110130420 Isoquinolinone derivatives as nk3 antagonists |
| 06/02/2011 | US20110130419 Novel salt of isoquinoline compound and crystal thereof |
| 06/02/2011 | US20110130418 Substituted phenylenediamines as inhibitors of the interaction between mdm2 and p53 |
| 06/02/2011 | US20110130417 New azacyclic derivatives |
| 06/02/2011 | US20110130416 Pharmaceutical composition for treating hypertension and metabolic syndrome and use thereof |
| 06/02/2011 | US20110130415 Protein kinase c inhibitors and uses thereof |
| 06/02/2011 | US20110130414 Novel fused thiazolo and oxazolo pyrimidinones |
| 06/02/2011 | US20110130413 Substituted quinazolines |
| 06/02/2011 | US20110130412 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
| 06/02/2011 | US20110130411 Process for preparing methyl carbamate and its purification for use as pharmaceutically active compound |
| 06/02/2011 | US20110130410 Process for preparing methyl methylcarbamate and its purification for use as pharmaceutically active compound |
| 06/02/2011 | US20110130409 Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders |
| 06/02/2011 | US20110130408 Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists |
| 06/02/2011 | US20110130407 Isoquinolinone derivatives as nk3 antagonists |
| 06/02/2011 | US20110130406 Pyrazolo-pyridines as tyrosine kinase inhibitors |
| 06/02/2011 | US20110130405 Substituted quinazolines as blood platelet lowering agents |
| 06/02/2011 | US20110130404 Quinoxalinedione derivatives |
| 06/02/2011 | US20110130403 Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors |
| 06/02/2011 | US20110130402 Heteroaromatic glucokinase activators |
| 06/02/2011 | US20110130401 New chemical compounds |
| 06/02/2011 | US20110130400 Trpv4 antagonists |
| 06/02/2011 | US20110130399 Phthalazine Derivatives with Angiogenesis Inhibiting Activity |
| 06/02/2011 | US20110130398 Spiroindolinone pyrrolidines |
| 06/02/2011 | US20110130397 Pyrrolinone compounds as inhibitors of bacterial peptidyl trna hydrolase and uses thereof |
| 06/02/2011 | US20110130396 Imidazothiadiazole derivatives |
| 06/02/2011 | US20110130395 P13k isoform selective inhibitors |
| 06/02/2011 | US20110130394 Pharmaceutical compounds |
| 06/02/2011 | US20110130393 Inhibitors of janus kinases |
| 06/02/2011 | US20110130392 Method of Administering a Methylene Blue - Curcumin Analog for the Treatment of Alzheimer's Disease |
| 06/02/2011 | US20110130391 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 06/02/2011 | US20110130390 Use of COX-2 Inhibitors for the Treatment of Schizophrenia, Delusional Disorders, Affective Disorders, Autism or Tic Disorders |
| 06/02/2011 | US20110130389 Fumarate salt of 4-bromophenyl 1,4-diazabicyclo[3.2.2]nonane-4-carboxylate, crystalline forms thereof, preparation thereof and therapeutic use thereof |
| 06/02/2011 | US20110130388 Prophylactic or therapeutic agent for axial myopia |
| 06/02/2011 | US20110130387 Sirtuin modulating compounds |
| 06/02/2011 | US20110130386 Dna-pk inhibitors |
| 06/02/2011 | US20110130385 Bicyclic Heterocylic Derivatives and Methods of Use |
| 06/02/2011 | US20110130384 Amide compound |
| 06/02/2011 | US20110130383 Use of Ion Channel Modulators in the Prophylaxis and Treatment of Inflammatory and Immunological Diseases |
| 06/02/2011 | US20110130382 Modulators of 5-ht receptors and methods of use thereof |
| 06/02/2011 | US20110130381 Small molecule inhibitors of plasmodium falciparum dihydroorotate dehydrogenase |
| 06/02/2011 | US20110130380 Heteroaryl Kinase Inhibitors |
| 06/02/2011 | US20110130379 Piperazine derivatives used as cav2.2 calcium channel modulators |
| 06/02/2011 | US20110130378 Ezetimibe process and composition |
| 06/02/2011 | US20110130377 Substituted aryloxazoles and their use |
| 06/02/2011 | US20110130376 New no releasing steroids derivatives |
| 06/02/2011 | US20110130375 New no-releasing steroids for the treatment of retina and macula lutea diseases |
| 06/02/2011 | US20110130374 Small Pyrimidine Derivatives and Methods of Use Thereof |
| 06/02/2011 | US20110130373 Methods for administration and formulations for the treatment of regional adipose tissue |
| 06/02/2011 | US20110130372 Composition comprising estrone and hydrocortisone for use in the topical treatment of baldness |
| 06/02/2011 | US20110130371 C-ring-substituted pregn-4-ene-21,17-carbolactones, and pharmaceutical preparations comprising the same |
| 06/02/2011 | US20110130370 Pharmaceutical composition comprising a strontium salt, vitamin D and A cyclodextrin |
| 06/02/2011 | US20110130369 Use of fts for the treatment of myocardial ischemia/reperfusion injury |
| 06/02/2011 | US20110130368 Derivatives of 4- or 5-aminosalicylic acid |
| 06/02/2011 | US20110130367 Combination Therapy for Treating Proliferative Diseases |
| 06/02/2011 | US20110130366 Fosaprepitant dimeglumine intermediate, neutral fosaprepitant, and amorphous fosaprepitant dimeglumine and processes for their preparations |
| 06/02/2011 | US20110130365 Fluorinated Heteroaryls |
| 06/02/2011 | US20110130364 Pyrrolopyridine derivatives substituted with cyclic amino group |
| 06/02/2011 | US20110130363 Benzopyran and benzoxepin pi3k inhibitor compounds and methods of use |
| 06/02/2011 | US20110130362 A2b adenosine receptor antagonists |
| 06/02/2011 | US20110130361 Silicon derivatives as histone deacetylase inhibitors |
| 06/02/2011 | US20110130360 Preventing or reducing oxidative stress or oxidative cell injury |
| 06/02/2011 | US20110130359 Methods for preventing or reducing neurotoxicity associated with administering dpd inhibitors in combination with 5-fu and 5-fu prodrugs |
| 06/02/2011 | US20110130358 Method for transdifferentiation of body tissues |
| 06/02/2011 | US20110130357 Aminoglycosides: Synthesis and Use as Antifungals |
| 06/02/2011 | US20110130356 Morphine and morphine precursors |
| 06/02/2011 | US20110130355 Use of sophoricoside in the manufacture of medicaments |
| 06/02/2011 | US20110130354 Sulfated oligosaccharide derivatives |
| 06/02/2011 | US20110130353 Highly purified antiendotoxin compound |
| 06/02/2011 | US20110130352 The use of the effective fraction of alkaloids from mulberry twig in preparing hypoglycemic agents |
| 06/02/2011 | US20110130351 Glycolipid fraction from cyanobacteria for treatment of diseases of the oral cavity |
| 06/02/2011 | US20110130349 Compounds and Methods for Treating Toll-Like Receptor 2-Related Diseases and Conditions |
| 06/02/2011 | US20110130343 Immunity-inducing agent and method for detection of cancer |
| 06/02/2011 | US20110130341 Method and kit for detection of cancer, and therapeutic agent for cancer |
| 06/02/2011 | US20110130340 Methods of identifying anti-cancer agents and uses thereof |
| 06/02/2011 | US20110130337 Polymorphisms associated with parkinson's disease |
| 06/02/2011 | US20110130335 Therapeutic agent and test agent for disease with myocardial necrosis |
| 06/02/2011 | US20110130327 Multi-Arm Amines and Uses Thereof |
| 06/02/2011 | US20110129896 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3Beta PROTEIN AND PROTEIN COMPLEXES |
| 06/02/2011 | US20110129883 Inactivation of genes of the mep pathway |
| 06/02/2011 | US20110129813 2'-branched nucleosides and flaviviridae mutation |
| 06/02/2011 | US20110129801 Compositions and methods to prevent and treat dry socket post-operatively after tooth extraction surgery |
| 06/02/2011 | US20110129553 Process for the preparation of sour cherry seed extract, use of the extract for the preparation of pharmaceutical compositions and pharmaceutical compositions containing said extract |
| 06/02/2011 | US20110129550 Cancer treatment method |
| 06/02/2011 | US20110129549 Tricyclic benzo[5,6]cyclohepta[1,2-b]pyridine derivatives and uses thereof |
| 06/02/2011 | US20110129548 Immunopotentiating Compositions Comprising Beta-1, 3/1, 6-D-Glucan and Uses Thereof |
| 06/02/2011 | US20110129546 Dermatological pharmaceutical composition for the treatment of skin inflammation diseases, such as dermatitis, atopic dermatitis, vitiligo, alopecia areata, acne, psoriasis, pruritus or combinations of same |
| 06/02/2011 | US20110129544 Bone/Cartilage Formation-Stimulation Agent |